Liver enzymes and cardiovascular outcomes: A new research agenda
Yusuf Yilmaz, Ramazan Kurt, Cem Kalayci – 23 November 2010
Yusuf Yilmaz, Ramazan Kurt, Cem Kalayci – 23 November 2010
Sundararajah Thevananther – 23 November 2010
Ajay Duseja, Balkrishan Sharma, Amit Kumar, Shweta Kapil, Ashim Das, Radha K. Dhiman, Yogesh K. Chawla – 23 November 2010
Hong‐Fang Ji – 23 November 2010
Nicolas Moniaux, Haiyan Song, Marion Darnaud, Kévin Garbin, Michelle Gigou, Claudia Mitchell, Didier Samuel, Laure Jamot, Paul Amouyal, Gilles Amouyal, Christian Bréchot, Jamila Faivre – 19 November 2010 – Acute liver failure (ALF) is a rare syndrome with a difficult clinical management and a high mortality rate. During ALF, several molecular pathways governing oxidative stress and apoptosis are activated to induce massive tissue injury and suppress cell proliferation.
Tao Li, Xu‐Ting Zhi, San‐Yuan Hu – 19 November 2010
Rachel A. Lindor, Keith D. Lindor – 19 November 2010
Evaggelia Liaskou, Marika Karikoski, Gary M. Reynolds, Patricia F. Lalor, Chris J. Weston, Nick Pullen, Marko Salmi, Sirpa Jalkanen, David H. Adams – 19 November 2010 – Primary sclerosing cholangitis (PSC) and autoimmune hepatitis are hepatic complications associated with inflammatory bowel disease (IBD). The expression of mucosal addressin cell adhesion molecule 1 (MAdCAM‐1) on mucosal endothelium is a prerequisite for the development of IBD, and it is also detected on the hepatic vessels of patients with liver diseases associated with IBD.
Andreas Lanitis, Christian Toso – 19 November 2010